ArticleAmerican journal of respiratory and critical care medicine2022
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension.
Open access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 57 citations in OpenAlex.
- Chronic Thromboembolic Pulmonary Hypertension as an Inflammation-Angiogenesis Disorder: From Thrombus Persistence to Dual Pulmonary Vasculopathy.Reviews in cardiovascular medicine · 2026Review
- Antiphospholipid Syndrome in Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Pulmonary Disease without Pulmonary Hypertension: Prevalence and Clinical Impact in a Dutch Cohort.TH open : companion journal to thrombosis and haemostasis · 2026Article
- Overexpression of PRDX2 alleviates chronic thromboembolic pulmonary hypertension by modulating inflammation and mitophagy.Scientific reports · 2025Article
- Nomogram model for identifying portal vein thrombosis in patients with decompensated cirrhosis.European journal of gastroenterology & hepatology · 2025Article
- Distinct endothelial cells in chronic thromboembolic pulmonary hypertension.NPJ cardiovascular health · 2025Article
- The Role of the Pulmonary Vascular Microenvironment in Chronic Thromboembolic Pulmonary Hypertension.Pulmonary circulation · 2025Review
- The genetics of chronic thromboembolic pulmonary hypertension: no longer a stab in the dark.ERJ open research · 2025Article
- Rare variants inERJ open research · 2025Article
- Endothelial Features Along the Pulmonary Vascular Tree in Chronic Thromboembolic Pulmonary Hypertension: Distinctive or Shared Facets?Pulmonary circulation · 2025Article
- Thrombocytopenia in Severe Fever with Thrombocytopenia Syndrome Due to Platelets With Altered Function Undergoing Cell Death Pathways.The Journal of infectious diseases · 2025Article
- Iloprost Concentration-Dependently Attenuates Platelet Function and Apoptosis by Elevating PKA Activity.Journal of cellular and molecular medicine · 2025Article
- Endoplasmic reticulum-associated degradation mitigates atherosclerosis by maintaining cellular homeostasis.Frontiers in physiology · 2025Review
- Construction and validation of a predictive model for postoperative stent occlusion in patients undergoing iliac vein stenting based on an explainable machine learning model.Frontiers in surgery · 2025Article
- Chronic thromboembolic pulmonary disease.The European respiratory journal · 2024Review
- An exploration into CTEPH medications: Combining natural language processing, embedding learning, in vitro models, and real-world evidence for drug repurposing.PLoS computational biology · 2024Article
- Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism? A Case Report and Discussion.Hamostaseologie · 2024Article
- When a DEAD-Box Protein Is the Key: A Novel Role for DDX5 in Lung Pericyte Dysfunction.American journal of respiratory cell and molecular biology · 2024Article
- Research progress on venous thrombosis development in patients with malignant tumors.World journal of clinical cases · 2024Review
- Single-Nuclei Characterization of Lacrimal Gland in Scopolamine-Induced Dry Eye Disease.Investigative ophthalmology & visual science · 2024Article
- Serum ASGR2 level: an efficacy biomarker for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.Frontiers in immunology · 2024Article
Corrections and comments
- Commented on by
Authors and funding
21 authors at 6 institutions in 3 countries.
Xue D ManzDepartment of Pulmonary Medicine and.
Robert SzulcekDepartment of Pulmonary Medicine and.
Xiaoke PanDepartment of Pulmonary Medicine and.
Petr SymerskyDepartment of Cardio-thoracic Surgery.
Chris DickhoffDepartment of Cardio-thoracic Surgery.
Jisca MajoléeDepartment of Physiology, Amsterdam University Medical Center, Vrije Universiteit University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
Veerle KremerDepartment of Physiology, Amsterdam University Medical Center, Vrije Universiteit University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
Elisabetta MichielonDepartment of Molecular Cell Biology and Immunology, and.
Ekaterina S JordanovaCenter for Gynecologic Oncology Amsterdam, and.
Teodora RadonicDepartment of Pathology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.
Irene V BijnsdorpDepartment of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands; and.
Sander R PiersmaDepartment of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands; and.
Thang V PhamDepartment of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands; and.
Connie R JimenezDepartment of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands; and.
Anton Vonk NoordegraafDepartment of Pulmonary Medicine and.
Frances S de ManDepartment of Pulmonary Medicine and.
Reinier A BoonDepartment of Physiology, Amsterdam University Medical Center, Vrije Universiteit University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
Jan VoorbergDepartment of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Academic Medical Center, Amsterdam, the Netherlands.
Peter L HordijkDepartment of Physiology, Amsterdam University Medical Center, Vrije Universiteit University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
Jurjan AmanDepartment of Pulmonary Medicine and.
Harm Jan BogaardDepartment of Pulmonary Medicine and.
Amsterdam University Medical Centers · NLCancer Center Amsterdam · NLAmsterdam UMC Location University of Amsterdam · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLGynecologic Oncology Group · USHumboldt-Universität zu Berlin · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hypertension, Pulmonaryvon Willebrand FactorEndothelial CellsEndothelium, VascularEpigenesis, GeneticHumansPlatelet AggregationProteomicsvon Willebrand Factorchronic thromboembolic pulmonary hypertensionendothelial cellsepigeneticsnuclear factor κBvon Willebrand factor
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.